<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B40F2188-08EB-4C85-BB2D-8BC835030569"><gtr:id>B40F2188-08EB-4C85-BB2D-8BC835030569</gtr:id><gtr:name>Genetic Epidemiology of Parkinson's Disease (GEO-PD)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B6C9212C-7F31-4397-9286-CFC3D825754F"><gtr:id>B6C9212C-7F31-4397-9286-CFC3D825754F</gtr:id><gtr:name>Cure Parkinson's Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CE3FD7E0-3664-4B1E-9B3A-B30C8F846C6C"><gtr:id>CE3FD7E0-3664-4B1E-9B3A-B30C8F846C6C</gtr:id><gtr:name>Peninsula College Of Medecine and Dentistry Foundation</gtr:name><gtr:address><gtr:line1>Harscombe House 1 Darklake View
Estover</gtr:line1><gtr:city>Plymouth</gtr:city><gtr:postCode>PL6 7TL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8319F78A-DCBD-49F6-BE00-78E1CD75CDA9"><gtr:id>8319F78A-DCBD-49F6-BE00-78E1CD75CDA9</gtr:id><gtr:name>University of York</gtr:name><gtr:address><gtr:line1>Heslington</gtr:line1><gtr:line4>York</gtr:line4><gtr:line5>North Yorkshire</gtr:line5><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/961756BF-E31F-4A13-836F-0A09BA02385C"><gtr:id>961756BF-E31F-4A13-836F-0A09BA02385C</gtr:id><gtr:name>University of Exeter</gtr:name><gtr:address><gtr:line1>University of Exeter</gtr:line1><gtr:line2>Clydesdale House</gtr:line2><gtr:line3>Clydesdale Road</gtr:line3><gtr:line4>Exeter</gtr:line4><gtr:postCode>EX4 4QX</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/7801F008-7C77-45E7-90E9-4345B47D138E"><gtr:id>7801F008-7C77-45E7-90E9-4345B47D138E</gtr:id><gtr:name>University of Plymouth</gtr:name><gtr:department>Sch of Biomedical &amp; Biological Sciences</gtr:department><gtr:address><gtr:line1>Drake Circus</gtr:line1><gtr:line4>Plymouth</gtr:line4><gtr:line5>Devon</gtr:line5><gtr:postCode>PL4 8AA</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7801F008-7C77-45E7-90E9-4345B47D138E"><gtr:id>7801F008-7C77-45E7-90E9-4345B47D138E</gtr:id><gtr:name>University of Plymouth</gtr:name><gtr:address><gtr:line1>Drake Circus</gtr:line1><gtr:line4>Plymouth</gtr:line4><gtr:line5>Devon</gtr:line5><gtr:postCode>PL4 8AA</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B40F2188-08EB-4C85-BB2D-8BC835030569"><gtr:id>B40F2188-08EB-4C85-BB2D-8BC835030569</gtr:id><gtr:name>Genetic Epidemiology of Parkinson's Disease (GEO-PD)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B6C9212C-7F31-4397-9286-CFC3D825754F"><gtr:id>B6C9212C-7F31-4397-9286-CFC3D825754F</gtr:id><gtr:name>Cure Parkinson's Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CE3FD7E0-3664-4B1E-9B3A-B30C8F846C6C"><gtr:id>CE3FD7E0-3664-4B1E-9B3A-B30C8F846C6C</gtr:id><gtr:name>Peninsula College Of Medecine and Dentistry Foundation</gtr:name><gtr:address><gtr:line1>Harscombe House 1 Darklake View
Estover</gtr:line1><gtr:city>Plymouth</gtr:city><gtr:postCode>PL6 7TL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8319F78A-DCBD-49F6-BE00-78E1CD75CDA9"><gtr:id>8319F78A-DCBD-49F6-BE00-78E1CD75CDA9</gtr:id><gtr:name>University of York</gtr:name><gtr:address><gtr:line1>Heslington</gtr:line1><gtr:line4>York</gtr:line4><gtr:line5>North Yorkshire</gtr:line5><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/961756BF-E31F-4A13-836F-0A09BA02385C"><gtr:id>961756BF-E31F-4A13-836F-0A09BA02385C</gtr:id><gtr:name>University of Exeter</gtr:name><gtr:address><gtr:line1>University of Exeter</gtr:line1><gtr:line2>Clydesdale House</gtr:line2><gtr:line3>Clydesdale Road</gtr:line3><gtr:line4>Exeter</gtr:line4><gtr:postCode>EX4 4QX</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/EAE9D337-6F92-4D71-8C4A-908F26841B4D"><gtr:id>EAE9D337-6F92-4D71-8C4A-908F26841B4D</gtr:id><gtr:firstName>Camille</gtr:firstName><gtr:surname>Carroll</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0501542"><gtr:id>33718703-D984-4363-A599-C512DFF0FF14</gtr:id><gtr:title>Molecular genetic studies of iron metabolism in Parkinson's disease and related neurodegenerative disorders</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0501542</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>Dysregulated iron homeostasis occurs in Parkinson?s disease (PD) and may be central to disease pathogenesis or progression, primarily due to impairment of mitochondrial function. We hypothesize that alteration in the expression of key genes and their resultant proteins involved in neuronal iron homeostasis may underlie neuronal iron dysregulation in PD. We have identified three neuronal proteins for study: the lactoferrin receptor (involved in iron uptake and demonstrated to be increased in PD nigra), mitochondrial ferritin (an iron storage protein that protects mitochondria from iron-mediated oxidative stress) and ferroportin (important for iron export, increased expression protecting neurons from iron-mediated toxicity). The specific aims of this project are: 

1. To accurately define the expression of the lactoferrin receptor, ferroportin and mitochondrial ferritin in human post mortem tissue in regions affected by Parkinson?s disease compared with controls. 
&amp;middot; Immunohistochemistry and in situ hybridization studies will be performed using semi-quantitative techniques to determine levels of gene and protein expression in substantia nigra and other regions involved in PD.
&amp;middot; Should differences be found, the study will be extended to include other conditions associated with Lewy body pathology such as Dementia with Lewy bodies.
2. To investigate whether susceptibility to developing PD may be conferred by polymorphisms in genes encoding the three proteins.
&amp;middot; DNA samples will be collected from people with PD and spouse/carer controls (estimated accrual rate of 200 PD and 150 control samples/yr).
&amp;middot; SNPs will be identified, prioritised and genotyped by various methods including allele specific PCR, restriction digestion and sequencing.
&amp;middot; Genotype and allele frequencies will be compared in cases and controls.
3. To investigate the effect of oxidative stress on gene and protein expression in a cell culture system.
&amp;middot; The effects of oxidative stress on exf the genes and proteins will be assessed in human neuroblastoma cells by real time PCR and Western blotting following exposure of the cells to oxidative stress.
&amp;middot; Levels of gene expression will be modulated using gene knockdown techniques and the effect on cell survival following exposure to oxidative insults assessed.
&amp;middot; Site-directed mutagenesis will be used to assess the functional effects of any disease-associated polymorphisms.

This study will add significantly to our understanding of the role of iron regulation in the pathogenesis of PD. If the mechanisms underlying neuronal degeneration can be identified, it may be possible to intervene therapeutically in patients with early PD to prevent pathological spread and hence disease progression.</gtr:technicalSummary><gtr:fund><gtr:end>2010-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>746188</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of York</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Health Sciences</gtr:department><gtr:description>Non-motor symptoms in PD</gtr:description><gtr:id>DC4AF709-9EA5-43AC-83B8-4E056467E27C</gtr:id><gtr:impact>Grant application submitted</gtr:impact><gtr:outcomeId>YZKVt4FELMQ-2</gtr:outcomeId><gtr:partnerContribution>Designing a clinical studyCollaborating in the design of the non-motor symptoms in PD study</gtr:partnerContribution><gtr:piContribution>We are the principal investigators in designing this study of non-motor symptoms in Parkinson's disease</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cure Parkinson's Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Self-assessment tool</gtr:description><gtr:id>35BE2E28-6BB8-4F88-BF5E-F5AB006D09AD</gtr:id><gtr:impact>Refining the self-assessment tool which will be distributed nationally to PD patients</gtr:impact><gtr:outcomeId>R7eLRn8dsag-1</gtr:outcomeId><gtr:partnerContribution>The Self-Assessment Tool was designed by the Cure Parkinson's Trust</gtr:partnerContribution><gtr:piContribution>We are establishing a patient register of all patients with PD who have an interest in research. We were able to utilise the register to assist with this pilot of a self-assessment tool in PD.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Aberdeen</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Applied Health Sciences</gtr:department><gtr:description>Non-motor symptoms in PD</gtr:description><gtr:id>F6D4694A-2F48-4815-A028-43546D6EEBF4</gtr:id><gtr:impact>Grant application submitted</gtr:impact><gtr:outcomeId>YZKVt4FELMQ-1</gtr:outcomeId><gtr:partnerContribution>Designing a clinical studyCollaborating in the design of the non-motor symptoms in PD study</gtr:partnerContribution><gtr:piContribution>We are the principal investigators in designing this study of non-motor symptoms in Parkinson's disease</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Peninsula College of Medicine &amp; Dentistry</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Cannabinoids in PD</gtr:description><gtr:id>6EF8B016-D2C8-4EE0-AD7B-EC0BBC05DE94</gtr:id><gtr:impact>Abstracts at national and international meetings; grant applications submitted; publication submitted</gtr:impact><gtr:outcomeId>5B9A09BB3CB-1</gtr:outcomeId><gtr:partnerContribution>PhD student</gtr:partnerContribution><gtr:piContribution>Using same model to investigate neuroprotective mechanisms of cannabinoids</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Genetic Epidemiology of Parkinson's Disease (GEO-PD)</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>GeoPD</gtr:description><gtr:id>3755944F-209F-4E8F-B7A3-1EC263DB6382</gtr:id><gtr:impact>No outputs as yet.</gtr:impact><gtr:outcomeId>erYgVtb4fwC-1</gtr:outcomeId><gtr:partnerContribution>Provide projects for which our samples can be used.</gtr:partnerContribution><gtr:piContribution>We will help develop projects and provide samples to the consortium.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Exeter</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>College of Engineering, Mathematics &amp; Physical Sciences</gtr:department><gtr:description>The Cotton-Mouton Effect</gtr:description><gtr:id>04AA486E-B315-440E-909F-50E455DCB5A1</gtr:id><gtr:impact>Grant application submitted</gtr:impact><gtr:outcomeId>YU7oJgsMKw7-1</gtr:outcomeId><gtr:partnerContribution>The principle investigators provided the technical expertise.</gtr:partnerContribution><gtr:piContribution>We are providing clinical input into this study of the magneto-optic properties of blood iron-storage compounds and whether they may be altered in neurodegenerative disease</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Neurology</gtr:department><gtr:description>Huw Morris Genetics</gtr:description><gtr:id>2740A5C6-2029-4240-AD14-87A845DF7050</gtr:id><gtr:impact>Paper in preparation.</gtr:impact><gtr:outcomeId>56dd92cece9608.36099410-1</gtr:outcomeId><gtr:partnerContribution>Our collaborators have analysed the samples using new genetic analysis techniques as part of larger study.</gtr:partnerContribution><gtr:piContribution>We collected in excess of 2000 DNA samples as part of the MRC-funded fellowship.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Prodendron newsletter</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>6C5DEF73-23A6-4266-A537-B6CC091F0EAE</gtr:id><gtr:impact>short article for newsletter

none</gtr:impact><gtr:outcomeId>B04541AC035</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2008,2009,2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>PD Research Forum</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>67121B12-F744-4E44-A8CC-67C49CD31D7B</gtr:id><gtr:impact>About 20 participants heard about PD research ongoing in the Peninsula of Devon and Cornwall, including the laboratory research sponsored by this grant

None</gtr:impact><gtr:outcomeId>JKmj6ZAsFp2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>departmental meetings - Plymouth</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>B97CD65F-1062-42E7-A5DE-7EDC8A620FCB</gtr:id><gtr:impact>members of clinical neurology research group, visiting neurologists and interested other neuroscientists and neurologists

none</gtr:impact><gtr:outcomeId>886C4A6C79C</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2008,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talks at PUK meetings</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>EB23A894-D2F0-414D-9C79-ABCDBE92E793</gtr:id><gtr:impact>Up to 100 attendees. DIscussed ongoing research.

Positive feedback from patients wanting to know more about research.</gtr:impact><gtr:outcomeId>Gof1gj9H8F8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2011,2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PUPSMD Internal PhD studentship</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>University of Plymouth</gtr:fundingOrg><gtr:id>E6586D64-F527-495F-9A96-B9BD2B908643</gtr:id><gtr:outcomeId>56dd9133158b80.61387003</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PUPSMD Internal PhD Studentship</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>University of Plymouth</gtr:fundingOrg><gtr:id>675946F6-6B25-4F58-B7F1-DD9E0958F2B4</gtr:id><gtr:outcomeId>56dd9174093d66.25801227</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>45000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Peninsula Medical School internal PhD studentship</gtr:description><gtr:end>2012-08-02</gtr:end><gtr:fundingOrg>Peninsula College of Medicine &amp; Dentistry</gtr:fundingOrg><gtr:id>69A5382A-F04E-4AA6-B4FD-D279C2ED86B6</gtr:id><gtr:outcomeId>6942A7610480</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4720</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>British Neuropathological Society Small Grants Scheme/British Neuropathological Society</gtr:description><gtr:end>2011-10-02</gtr:end><gtr:fundingOrg>British Neuropathological Society</gtr:fundingOrg><gtr:id>2E1A8E72-85E7-4E32-B6D4-A7F6C68DE919</gtr:id><gtr:outcomeId>Tb9ckRzLdCs0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2010-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>48000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Lifelong Learning Programme EU</gtr:description><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>527943-LLP-2012-PT-GRUNDTVIG-GMP</gtr:fundingRef><gtr:id>0785DB8D-CD97-45DD-8383-1AC9A641678B</gtr:id><gtr:outcomeId>JxHMUnckPaM</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>DNA Collection from people with Parkinson's disease and age-matched controls.</gtr:description><gtr:id>07AC4558-D08B-40D9-89A3-762255D52321</gtr:id><gtr:impact>Publication.</gtr:impact><gtr:outcomeId>58c6cd88baed70.98723692</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>PD DNA</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>DNA samples from patients with neurodegenerative disease and controls</gtr:description><gtr:id>E6E18F3A-B5BE-4B20-A9DF-8214951D67B8</gtr:id><gtr:impact>collaboration with GeoPD and UCL</gtr:impact><gtr:outcomeId>4DF94BDF52B</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Neurodegenerative Diseases DNA bank</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Register of all patient with PD in the South West with an interest in taking part in research</gtr:description><gtr:id>D96BD3CE-C717-481A-9522-54AD12769CE8</gtr:id><gtr:impact>Utilising the register enabled the Cure Parkinson Trust to gain sufficient feedback in the design of its Self Assessment Tool, which is now being utilised nationally.

The register was successfully used to recruit to a study of rivastigmine for falls in Parkinson's disease - recently reported in Lancet Neurology.</gtr:impact><gtr:outcomeId>caj3S6yGbHU</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>PRO-DeNDRoN</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>BF0B683C-4A67-4D98-99B8-9C294D490D01</gtr:id><gtr:title>The role of insulin-like growth factors signaling in merlin-deficient human schwannomas.</gtr:title><gtr:parentPublicationTitle>Glia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cc3109aaba93db145b181ef7a6439111"><gtr:id>cc3109aaba93db145b181ef7a6439111</gtr:id><gtr:otherNames>Ammoun S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0894-1491</gtr:issn><gtr:outcomeId>pm_15683_23_22821509</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5BFC4690-AE15-49E2-9013-7205AF530A85</gtr:id><gtr:title>Changes in iron-regulatory gene expression occur in human cell culture models of Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Neurochemistry international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64bafb84623a080115e93c22366818e8"><gtr:id>64bafb84623a080115e93c22366818e8</gtr:id><gtr:otherNames>Carroll CB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0197-0186</gtr:issn><gtr:outcomeId>58c2f5ee1ea495.48740499</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE54F688-B7BD-49CB-9BB0-5A0DBE0FD7C2</gtr:id><gtr:title>CBD &amp;amp; THC - the two faces of cannabis</gtr:title><gtr:parentPublicationTitle>Cell Science Reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/295b3e9190cc1cf3a9f0eddaacb1263e"><gtr:id>295b3e9190cc1cf3a9f0eddaacb1263e</gtr:id><gtr:otherNames>Zeissler Marie-Louise</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>EmwVtDRB4Eh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5B9A0FF-5C56-4B10-A81C-B7AE1265565B</gtr:id><gtr:title>Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/abb077c55d40a95e0c99027b072d63fb"><gtr:id>abb077c55d40a95e0c99027b072d63fb</gtr:id><gtr:otherNames>Zeissler ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>58c2f5ede50298.12310394</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B8AC1D5-B397-4563-8531-1143E08D4D30</gtr:id><gtr:title>POMD11 Cannabinoids are neuroprotective in a human cell culture model of Parkinson's disease</gtr:title><gtr:parentPublicationTitle>Journal of Neurology, Neurosurgery &amp; Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0756fe92364a47b0ab316b4474249604"><gtr:id>0756fe92364a47b0ab316b4474249604</gtr:id><gtr:otherNames>Carroll C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>NiMEkmLB1w8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D41F1FA-48E4-4201-920E-6C13CB61DFCF</gtr:id><gtr:title>??-tetrahydrocannabinol (??-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64bafb84623a080115e93c22366818e8"><gtr:id>64bafb84623a080115e93c22366818e8</gtr:id><gtr:otherNames>Carroll CB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>pm_15683_23_22236282</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9FB829A5-BD6F-443B-A1D7-20C1D3587020</gtr:id><gtr:title>Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b6f56a59bf0c127ea59004421ab9871"><gtr:id>0b6f56a59bf0c127ea59004421ab9871</gtr:id><gtr:otherNames>Lubbe SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>58c2f59b7a8ed4.95392317</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0501542</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>